Navigation Links
InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting
Date:9/11/2009

BURLINGTON, Mass., Sept. 11 /PRNewswire/ -- InfraReDx today announced its preliminary schedule of events at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, scheduled from Monday, September 21st to Friday, September 25th, in San Francisco, CA. at the Moscone Center. This scientific meeting is one of the world's largest events for those performing cardiac diagnostics and interventions.

The LipiScan(TM) Coronary Imaging System will be displayed in the "Emerging Technologies" section at booth # 2410. Schedule of InfraReDx Events at TCT 2009 are as follows:

Monday, September 21st

On behalf of Cardiovascular Research Foundation, Dr. James Muller, founder and CEO of InfraReDx, has been invited to participate as a guest speaker titled:

"Vulnerable Plaque: Emerging Directions for Diagnosis and Treatment: Near Infrared Spectroscopy I: Technology and validation."

  • 2:40 pm in room # 130 at the Moscone Center.

Friday, September 25th

InfraReDx sponsored Breakfast Symposium:

"Beyond Angiography: NIR Spectroscopy and Other Methods for Plaque Characterization."

  • 6:30 am Breakfast, 7:00 am Symposium in room #120 at the Moscone Center. Presenters include: Dr. Cindy Grines (Beaumont Hospital), Dr. Gregg W. Stone (Presbyterian/Columbia), Dr. Emmanouil Brilakis (Dallas VA), Dr. Brijeshwar Maini (Moffitt Heart and Vascular), Dr. Patrick Serruys (Erasmus Medical Center), and Dr. James E. Muller (InfraReDx).

About InfraReDx, Inc.

InfraReDx, Inc., headquartered in Burlington, Massachusetts, was founded in 1998 and is a privately-funded medical device company developing a fiber-optic, catheter-based, near-infrared (NIR)
'/>"/>

SOURCE InfraReDx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System
2. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
3. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
4. Scottsdale Facility to Be First in U.S. to Showcase True REST Technology
5. Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase
6. B. Braun Medical Inc. to Demonstrate Infusion Systems Technologies at HIMSS 2009 Interoperability Showcase
7. Anti-Aging Expo & Symposium Showcases in Charlotte on March 28th
8. InVitrias Cellastim Showcased in Nature Article
9. Xoft Showcases Interim Clincal Results for Breast Cancer Product and New Indications for Electronic Brachytherapy(eBx) at Astro Meeting
10. InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
11. ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 Medlytix, a national healthcare ... a key half-billion dollar milestone - the total ... provided in financial assistance to more than a ... of properly classifying charity care - in less ... of these hospitals enhanced their bottom lines and ...
(Date:12/16/2009)... 16 Ethicon, Inc., a Johnson & ... a worldwide leader in surgical care, and Acclarent, ... to designing, developing and commercializing devices that address ... today announced a definitive merger agreement whereby Ethicon ... approximately $785 million net of estimated cash on ...
(Date:12/16/2009)... 16 Hospira, Inc. (NYSE: HSP ... company, today announced that it will host a conference ... and projections for 2010 on Thursday, Feb. 4, 2010, ... release its fourth-quarter and full-year 2009 results earlier that ... conference call. ,, A live webcast of the conference ...
Breaking Medicine Technology:Healthcare Scoring System Allows Hospitals To Increase Charity Care 2Healthcare Scoring System Allows Hospitals To Increase Charity Care 3Healthcare Scoring System Allows Hospitals To Increase Charity Care 4Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4Dee Snider Leads 2009 March of Dimes Bikers for Babies 28R 29 48644 1Dee Snider Leads 2009 March of Dimes Bikers for Babies 28R 29 48644 2Oncology Program at Texas Health Dallas Receives Outstanding Achievement Award 48641 1Oncology Program at Texas Health Dallas Receives Outstanding Achievement Award 48641 2Protein Branded As Culprit in Mad Cow Disease 48638 1Protein Branded As Culprit in Mad Cow Disease 48638 2
... The Society of Gynecologic Oncologists (SGO) and the American ... a breast disease fellowship training program for gynecologic oncologists. ... the program provides support for a gynecologic oncologist to ... treatment of breast cancer and related disease. "As ...
... today announced that it has received clearance from ... the U.K. Medicines and Healthcare products Regulatory Agency ... AeroTrial(TM), of inhaled dry powder Aerovant in patients ... United States for AeroTrial, a double-blind, randomized, placebo-controlled, ...
Other Medicine Technology:SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists 2SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists 3Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma 2Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma 3
(Date:12/17/2009)... Neurological Stress Reduction Therapy or NSRTSM is found very effective ... such as allergies, asthma, migraines, chronic fatigue and a wide ... the country are using this holistic therapy including over 50 ... ... Allentown, PA (Vocus) December 16, 2009 -- BioVeda ...
(Date:12/16/2009)... -- If proposed health care legislation is enacted, ... insurance system. Approximately 18.4 million Californians and 161 ... upon employer-based insurance for their health care coverage. ... reform legislation entail specific requirements for employer-based insurance. ... for firms that currently comply with most new ...
(Date:12/16/2009)... 16 New Enterprise Associates, Inc. (NEA), ... that one of its portfolio companies, Acclarent, Inc., ... acquired by Ethicon, Inc., a Johnson & Johnson ... million (net of estimated cash on hand at ... to designing, developing and commercializing devices that address ...
(Date:12/16/2009)... -- Allscripts (Nasdaq: MDRX ) announced today ... the three and six months ended November 30, ... January 11, 2010. Allscripts management will host a ... earnings and other information at 8:30 AM Eastern ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal second quarter ...
(Date:12/16/2009)... Averting second, possibly deadly, attack is long-term goal, researchers ... Researchers have developed a tool to predict whether a ... of a first stroke. , "This is an important ... have a second stroke soon after a first stroke ... Dr. Hakan Ay, of Massachusetts General Hospital and Harvard ...
Breaking Medicine News(10 mins):Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 5Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:New Stroke Tool May Predict Early Recurrence 2
... have asked the World Health Organization to investigate the possibility ... of bird flu//. They are already ready to invest $1.9bn ... virus is already being done. ,Tony Blair while ... preparedness for an outbreak of bird flu insisted that precautions ...
... of neurobiology at the University of California, Irvine (UCI) ... that the experimental drug// AF267B is effective against both ... mice. ,This compound (AF267B) curbs both the ... well as another lesion, the tangles of protein called ...
... PhD, of the University of Reading in England, has said ... or antiperspirants and breast cancer. She says that he aluminum-based ... body.// ,"Lifetime exposure to estrogen is the risk ... said. "If the aluminum salts in antiperspirants enter the body ...
... as about 3,000 people in the steel town were affected by ... in a small group at a slum// cluster in Panposh on ... then, it has rapidly spread to other parts of the town. ... acute colic pain, said a senior district health official. ...
... A research team has now established that a delayed-release ... may be associated with less abuse, when compared to ... the form of an oral formulation have not been ... drug abuse. The results of the study can be ...
... For those who instantly saw it as a half full glass, ... your body will promote overall well-being// and also lower cardiovascular risk ... men in the age group of 64 to 84, the most ... and demeanor had been tracked for nearly 15 years. This study ...
Other Medicine News:Health News:Experimental Alzheimer’s Drug curbs the disease in mic 2Health News:Concerta, Drug Used in ADHD Treatment Less Likely To Result In Abuse 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: